Motives, frequency, predictors and outcomes of MRA discontinuation in a real-world heart failure population

Motives, frequency, predictors and outcomes of MRA discontinuation in a real-world heart failure population

Introduction Mineralocorticoid receptor antagonists (MRAs) reduce mortality and morbidity in patients with heart failure and reduced ejection fraction (HFrEF), but are largely underused. We evaluated the frequency, motives, predictors and outcomes of MRA discontinuation in a real-world heart failure...

Full description

Bibliographic Details
Main Authors: Krister Lindmark, Anna Jonsson Holmdahl, Gustav Wessberg, Helena Norberg, Adrian Söderström, Fredrik Valham, Ellinor Bergdahl
Format: Article
Language:English
Published: BMJ Publishing Group 2022-08-01
Series:Open Heart
Online Access:https://openheart.bmj.com/content/9/2/e002022.full

Internet

https://openheart.bmj.com/content/9/2/e002022.full

Similar Items